Berti, L., Irmler, M., Zdichavsky, M., Meile, T., Böhm, A., Stefan, N., . . . Staiger, H. (2015). Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol Metab.
Chicago ZitierstilBerti, Lucia, et al. "Fibroblast Growth Factor 21 Is Elevated in Metabolically Unhealthy Obesity and Affects Lipid Deposition, Adipogenesis, and Adipokine Secretion of Human Abdominal Subcutaneous Adipocytes." Mol Metab 2015.
MLA ZitierstilBerti, Lucia, et al. "Fibroblast Growth Factor 21 Is Elevated in Metabolically Unhealthy Obesity and Affects Lipid Deposition, Adipogenesis, and Adipokine Secretion of Human Abdominal Subcutaneous Adipocytes." Mol Metab 2015.